Acer Therapeutics Inc.
ACERDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069308
Acer Therapeutics Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 20, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $3.40M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Acer Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q3 2021
- Shares held
- 1.47M
- −57.4K (−3.8%) vs. Q3 2021
- Total value
- $3.35M
- −$561.0K (−14.3%) vs. Q3 2021
- New holders
- 6
- 4 more added
- Sold out
- 7
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 30 | $3.40M |
| Q2 2023 | 27 | $2.32M |
| Q1 2023 | 26 | $3.48M |
| Q4 2022 | 32 | $6.14M |
| Q3 2022 | 28 | $2.22M |
| Q2 2022 | 28 | $1.96M |
| Q1 2022 | 21 | $4.12M |
| Q4 2021 | 24 | $3.35M |
| Q3 2021 | 25 | $3.91M |
| Q2 2021 | 30 | $4.47M |
| Q1 2021 | 30 | $5.15M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Acer Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 901,290 | $2.06M | 0.13% | −12,907−1.4% | Reduced |
| Vanguard Group Inc | 178,880 | $408.0K | 0.00% | −2,860−1.6% | Reduced |
| BlackRock Inc. | 104,309 | $237.0K | 0.00% | +705+0.7% | Added |
| Goldman Sachs Group Inc | 95,343 | $217.0K | 0.00% | +10.0% | Added |
| Geode Capital Management, LLC | 84,761 | $194.0K | 0.00% | +20,737+32.4% | Added |
| State Street Corp | 24,965 | $57.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,482 | $44.0K | 0.00% | +2,822+16.9% | Added |
| Renaissance Technologies LLC | 17,400 | $40.0K | 0.00% | +17,400 | New |
| Raymond James & Associates | 16,200 | $37.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,576 | $29.0K | 0.01% | +12,576 | New |
| Bank of New York Mellon Corp | 11,133 | $25.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,233 | $3.00K | 0.00% | +1,233 | New |
| Larson Financial Group LLC | 922 | $2.00K | 0.00% | 00.0% | Unchanged |
| Burleson & Company, LLC | 365 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 179 | $412 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 26 | $0 | 0.00% | −5,150−99.5% | Reduced |
| Advisor Group Holdings, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 58 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1 | $0 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18 | $0 | 0.00% | +18 | New |
| Edge Wealth Management LLC | 50 | – | – | +50 | New |
| CoreCap Advisors, LLC | 96 | – | – | +96 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,681−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,002−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −13,488−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,591−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |